CLX Investment Company Announces Zonda Appearance at Largest Medical Device Manufacturing Event.

TEMECULA, Calif. -- CLX Investment Company, Inc. (OTCBB:CLXN) today announced that portfolio investment Zonda Inc. is attending the Medical Design & Manufacturing (MD&M) West trade show, billed as the largest event of its kind for the medical device industry, being held January 31 - February 2 in Anaheim, California.

Attending the show are members of both the Zonda and CLX management teams, including CLX chief executive officer Tammy D. Dunn. MD&M West features the latest advances in medical-grade materials, components, electronics, computer-aided design and manufacturing, production machinery, packaging, sterilization, quality systems, device communications, networking, and enterprise IT.

"As part of the global expansion strategy for Zonda, Inc., CLX is supporting its attendance at virtually all of the key industry events in 2006, and MD&M West allows Zonda to explore and evaluate additional potential industry relationships, as well as planning design and packaging upgrades for the next generation of its product line," stated Ms. Dunn.

Zonda Inc., a privately held company that specializes in test products that serve the medical diagnostic (IVD), food safety, and sanitation testing markets, is expanding the distribution of its product lines into broader markets around the world. The company's product line includes innovative, rapid, self-contained diagnostic device for the detection of Chlamydia, gonorrhea, yeast and Strep A. The Chlamydia test is currently being distributed in European markets and carries a CE mark for both professional point-of-care and over-the-counter use. The gonorrhea, yeast and Strep A tests carry CE marks for professional point-of-care use, and Zonda is seeking similar approvals for over-the-counter sales of these products. Each of the Zonda infectious disease tests are marketed as superior to their competition due to their comparable accuracy (compared directly to other testing methods), ease of use, compact design, long shelf life, rapid results, and cost effectiveness.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.asp.

About the Company

CLX Investment Company (www.clxinvestments.com) has elected to be regulated as a Business Development Company pursuant to Section 54 of the Investment Company Act of 1940, and is pursuing a business plan wherein the Company seeks to make investment in developing companies with the goal of providing return for its shareholders.

CLX has acquired a 49% interest in eStrategy Solutions, Inc. (www.clxinvestments.com/estrategysolutions), a Texas-based e-learning provider that has developed online training solutions for government entities and other professional organizations. The Company has made an investment in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards. CLX holds a 20% equity interest in Zonda, Inc. (www.zondainc.com), a privately held company that specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.